Table 4 Evaluation of Potential Risk Factors for eSVS® mesh supported saphenous vein grafts
From: One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts
Risk Factor | Patent | Occluded | P-Value |
|---|---|---|---|
Gender (n; %; male) | 11 (68.8) | 5 (31.3) | 1.00 |
Age (years; mean ± std) | 72.4 ± 8.2 | 65 ± 11.8 | 0.14 |
CAD in 1° relative (n; %) | 13 (76.5) | 4 (23.5) | 0.47 |
Arterial hypertension (n; %) | 14 (77.8) | 4 (22.2) | 0.26 |
Diabetes (n; %) | 7 (87.5) | 1 (12.5) | 0.34 |
Dyslipidemia (n; %) | 12 (75) | 4 (25) | 0.62 |
Smoking (n; %; current/former/never) | 2(100)/10(76.9)/2 (50) | 0 / 3 (23.1)/2 (50) | 0.56 |
Previous myocardial infarction (n;%) | 9 (69.2) | 4 (30.8) | 1.00 |
LVEF (%; mean ± std) | 50.8 ± 12.9 | 44.8 ± 5 | 0.13 |
SVG Harvest technique: endoscopic | 13 (76.5) | 4 (23.5) | 0.47 |
(n; %) | |||
SVG Harvest site : magna (n; %) | 13 (76.5) | 4 (23.5) | 0.47 |
SVG Varicosis (n; %) | 9 (75) | 3 (25) | 1.00 |
SVG Quality | 1 (25)/10 (83.3)/3 (100) | 3 (75)/2 (16.7)/0 | 0.06 |
(n; %; poor/moderate/good) | |||
Mesh size (n; %; 3.5 mm/4.0 mm/4.5 mm)1) | 3 (75)/9 (75)/2 (66.7) | 1 (25) / 3 (25)/1 (33.3) | 1.00 |
Perfusion (n; %; OPCAB/ECC/MECC) | 9 (81.8)/3 (60)/2 (66.7) | 2 (18.2)/2 (40)/1 (33.3) | 0.79 |
Aorta (n; %; Clamping/Heartstring) | 4 (50)/9 (90) | 4 (50)/1 (10) | 0.16 |
Coronary system (n; %; left/right) | 7 (87.5)/7 (63.6) | 1 (12.5)/4 (36.4) | 0.34 |
Coronary run-off (n; %; poor/moderate/good)2) | 1(33.3)/9 (75)/4 (100) | 2 (66.7)/3 (25)/0 | 0.12 |
Jumping graft (n; %) | 8 (88.9) | 1 (11.1) | 0.30 |
TTFM: Flow (ml/min; mean ± std) | 57.8 ± 28.9 | 64.4 ± 83.9 | 0.30 |
TTFM: Pulsatility index (mean ± std) | 1.7 ± 0.6 | 1.0 ± 0.2 | 0.03 |